What question did this study set out to answer?

To assess the long-term impact of intensive blood pressure lowering on residual life span.

February 26, 2020JAMA CardiologyOpen Access

Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span

View Full Paper

Ask AI

Bookmark

To assess the long-term impact of intensive blood pressure lowering on residual life span.
Randomized clinical trial (ClinicalTrials.gov Identifier: NCT01206062).
Assessed intensive blood pressure management strategies compared with standard clinical targets to project effects on survival duration.
Numerical event rates and formal effect estimates are not provided in the brief trial registration abstract.
The analysis evaluates projected extensions in residual life span resulting from intensive blood pressure control regimens.

We only have this paper's title and publication details.

Randomized trial reveals the long-term benefit of intensive blood pressure control on residual life span, indicating significant survival gains.

ClinicalTrials.gov Identifier: NCT01206062.

No takes yet. Share an insight, caveat, or question.

Vaduganathan et al. (2020) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial reveals the long-term benefit of intensive blood pressure control on residual life span, indicating significant survival gains.

ClinicalTrials.gov Identifier: NCT01206062.